Ethyol Approved for Use in the UK
WEST CONSHOHOCKEN, Pa--The Medicines Control Agency, the regulatory agency for the United Kingdom, has granted a product license for the marketing of Ethyol (amifostine), manufactured by U.S. Bioscience, Inc.
WEST CONSHOHOCKEN, Pa--The Medicines Control Agency, the regulatoryagency for the United Kingdom, has granted a product license forthe marketing of Ethyol (amifostine), manufactured by U.S. Bioscience,Inc.
Ethyol is a selective cytoprotective agent indicated for the reductionof neutropenia-related infection resulting from use of the combinationof cyclophosphamide (Cytoxan, Neosar) and cisplatin (Platinol)in patients with advanced ovarian carcinoma.
Approval of ethyol in this country suffered a set back when anadvisory committee failed to recommend it to the FDA.
![Radiotherapy is a very evidence-based subject. We can tell quite accurately how well we think [a patient] is going to do.](/_next/image?url=https%3A%2F%2Fcdn.sanity.io%2Fimages%2F0vv8moc6%2Fcancernetwork%2Feecaffda6ab0cbb4f4463586ace2f199eeefa8bf-400x401.jpg%3Ffit%3Dcrop%26auto%3Dformat&w=3840&q=75 "Radiotherapy is a very evidence-based subject. We can tell quite accurately how well we think [a patient] is going to do.")
